Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Synsam ABCHIX:SYNSAS 81 EV-to-OCF is 7.73 as of Sep. 21, 2026, which is 22% below its 10-year median of 9.93. GuruFocus rates CHIX:SYNSAS with a GF Score™ of 81/100 and a GF Value™ of kr66.95. The stock has 1 warning sign investors should review. Among 852 Medical Devices & Instruments companies, Synsam AB ranks worse than 50.12% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Synsam AB's Enterprise Value is kr10,451 Mil.
Synsam AB's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was kr1,352 Mil. Therefore, Synsam AB's EV-to-OCF for today is 7.73.
The historical rank and industry rank for Synsam AB's EV-to-OCF or its related term are showing as below:
CHIX:SYNSAs'
s EV-to-OCF Range Over the Past 10 Years
Min: 6.88 Med: 9.93 Max: 19.15
Current: 7.97
During the past 8 years, the highest EV-to-OCF of Synsam AB was 19.15. The lowest was 6.88. And the median was 9.93.
CHIX:SYNSAs's EV-to-OCF is ranked worse than 50.12% of 852
companies
in the Medical Devices & Instruments industry
Industry Median: 7.88
vs CHIX:SYNSAs: 7.97
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Synsam AB's share price for today is kr59.80.
Synsam AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr4.020.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Synsam AB EV-to-OCF Related Terms
Synsam AB EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Synsam AB's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:SYNSAS vs ISRG, BDX, RMD: EV-to-OCF Comparison
For the Medical Instruments & Supplies subindustry, Synsam AB's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Synsam AB EV-to-OCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Synsam AB's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Synsam AB's EV-to-OCF falls into.
Synsam AB's current Enterprise Value is kr10,451 Mil.
Synsam AB's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was kr1,352 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Synsam AB (CHIX:SYNSAS) has a EV-to-OCF of 7.73 as of Sep. 21, 2026. This is 22% below median its historical median of 9.93. Over the past decade, Synsam AB's EV-to-OCF has ranged from 6.88 to 19.15. According to the industry distribution chart, Synsam AB ranks #427 out of 852 companies in the Medical Devices & Instruments industry, placing it in the top 50.1%.
Is Synsam AB's EV-to-OCF too high?
Synsam AB's current EV-to-OCF of 7.73 is 22% below median its 10-year median of 9.93. Over the past 10 years, this metric has ranged from a low of 6.88 to a high of 19.15. The Medical Devices & Instruments industry median EV-to-OCF is 7.88. Synsam AB's value of 7.73 is 1.9% below this industry median. Based on the distribution chart, Synsam AB ranks #427 out of 852 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Synsam AB has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does Synsam AB's EV-to-OCF compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Synsam AB ranks #427 out of 852 companies for EV-to-OCF. This places Synsam AB in the lower half of its industry. The industry median EV-to-OCF is 7.88. Synsam AB's value of 7.73 is 1.9% below this benchmark. Historically, Synsam AB's own EV-to-OCF has ranged from 6.88 to 19.15 over the past decade. While the company's 10-year median is 9.93 vs. the industry median of 7.88, Synsam AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Devices & Instruments company?
The median EV-to-OCF among Medical Devices & Instruments companies is 7.88, based on 852 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Synsam AB's current EV-to-OCF of 7.73 is 1.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median EV-to-OCF is 7.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Synsam AB's current EV-to-OCF is 7.73, which is 22% below median its own 10-year median of 9.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synsam AB stock overvalued right now?
Synsam AB (CHIX:SYNSAS) has a current EV-to-OCF of 7.73. The stock's GF Value™ is kr66.95, compared to a current price of kr59.80 — trading 10.7% below its estimated fair value. The current EV-to-OCF is 7.73, which is 22% below median its 10-year median of 9.93 and 1.9% below the Medical Devices & Instruments industry median of 7.88. Synsam AB's overall GF Score™ is 81/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Synsam AB (CHIX:SYNSAS), the current EV-to-OCF is 7.73 as of Sep. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Synsam AB (CHIX:SYNSAS) Overvalued in 2026?
Based on GuruFocus' analysis, Synsam AB stock appears to be undervalued.
The current stock price of kr59.80 is trading 10.7% below its estimated GF Value™ of kr66.95.
Key valuation signals for CHIX:SYNSAS:
EV-to-OCF: 7.73 (22% below median its 10-year median of 9.93)
GF Value™: kr66.95 vs. price of kr59.80 (10.7% below fair value)
Industry Position: 1.9% below the Medical Devices & Instruments median (#427 of 852)
No single metric tells the full story. See the CHIX:SYNSAS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Synsam AB is a lifestyle company in optics and eye health in the Nordic region. The company offers various products and services in physical and digital stores, such as eye examinations, spectacles, sunglasses, sports spectacles, contact lenses, and accessories in optical retail, as well as spectacles subscriptions and related services under the name Synsam Lifestyle. Its stores are operated under the Synsam brand in Sweden, Norway, and Finland, and under the Profil Optik brand in Denmark and Iceland. The company comprises four segments: Sweden, which generates key revenue, Denmark, Norway, and Finland.
81GF Score
Get the complete analysis for CHIX:SYNSAS
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:SYNSAS has been successfully added to your 
